drugset / Trial / NCT05161598
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
Summary
Teclistamab pre-approval access in relapsed or refractory multiple myeloma.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teclistamab | Monoclonal antibody | — | Subcutaneous |